Interleukin-17: A mediator of inflammatory responses

Cellular and Molecular Life Sciences

Volumn 61, Issue 5, 2004, Pages 567-579

  Witowski, J ^a,b   Ksiazek K ^a   Jorres A ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokines; Granulopoiesis; IL 17; Inflammation; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 2; CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROSTAGLANDIN E2; RANTES; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL CELL; ANIMAL MODEL; CORNEA DISEASE; ENTERITIS; GRANULOPOIESIS; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY ALLOGRAFT REJECTION; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; MOUSE; MULTIPLE SCLEROSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PSORIASIS; RAT; REVIEW; RHEUMATOID ARTHRITIS; SKIN DISEASE; TUMOR GROWTH;

ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-17; NEUTROPHILS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

ANIMALIA; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 1642369092     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3228-z     Document Type: Review

References (142)

1. Dumont F. J. (2003) IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses. Expert Opin. Ther. Patents 13: 287-303
2. Kolls J. K., Kanaly S. T. and Ramsay A. J. (2003) Interleukin-17: an emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28: 9-11
3. Moseley T. A., Haudenschild D. R., Rose L. and Reddi A. H. (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174
4. Schwarzenberger P. and Kolls J. K. (2002) Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J. Cell Biochem. Suppl. 38: 88-95
5. Linden A. and Adachi M. (2002) Neutrophilic airway inflammation and IL-17. Allergy 57: 769-775
6. Spriggs M. K. (1997) Interleukin-17 and its receptor. J. Clin. Immunol. 17: 366-369
7. Rouvier E., Luciani M. F., Mattei M. G., Denizot F. and Golstein P. (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus saimiri gene. J. Immunol. 150: 5445-5456
8. Yao Z., Painter S. L., Fanslow W. C., Ulrich D., Macduff B. M., Spriggs M. K. et al. (1995) Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155: 5483-5486
9. -T cells. J. Interferon Cytokine Res. 16: 611-617
10. Yao Z., Fanslow W. C., Seldin M. F., Rousseau A. M., Painter S. L., Comeau M. R. et al. (1995) Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821
11. Biesinger B., Mueller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E. et al. (1992) Stable growth transformation of human T-lymphocytes by Herpevirus saimiri. Proc. Natl. Acad. Sci. USA 89: 3116-3319
12. Moore P. S., Boshoff C., Weiss R. A. and Chang Y. (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274: 1739-1744
13. Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A. and Mosmann T. R. (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230-1234
14. Alcami A. (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3: 36-50
15. Knappe A., Hiller C., Niphuis H., Fossiez F., Thurau M., Wittmann S. et al. (1998) The interleukin-17 gene of Herpesvirus saimiri. J. Virol. 72: 5797-5801
16. Patera A. C., Pesnicak L., Bertin J. and Cohen J. I. (2002) Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 299: 56-63
17. Hymowitz S. G., Filvaroff E. H., Yin J. P., Lee J., Cai L., Risser P. et al. (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F and implications for receptor binding. EMBO J. 20: 5332-5341
18. Fossiez F., Djossou O., Chomarat P., Flores R. L., Ait Y. S., Maat C. et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603
19. + T lymphocytes and its regulation by protein kinase A pathway. Cytokine 11: 257-266
20. +) T cells by cyclic AMP-dependent signal transduction pathway. Cytokine 10: 841-850
21. Happel K. I., Zheng M., Young E., Quinton L. J., Lockhart E., Ramsay A. J. et al. (2003) Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436
22. Ferretti S., Bonneau O., Dubois G. R., Jones C. E. andTrifilieff A. (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170: 2106-2112
23. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N. et al. (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438
24. Aarvak T., Chabaud M., Miossec P. and Natvig J. B. (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162: 1246-1251
25. Aarvak T., Chabaud M., Kallberg E., Miossec P. and Natvig J. B. (1999) Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand. J. Immunol. 50: 1-9
26. Albanesi C., Scarponi C., Cavani A., Federici M., Nasorri F. and Girolomoni G. (2000) Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma-and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115: 81-87
27. Infante-Duarte C., Horton H. F., Byrne M. C. and Kamradt T. (2000) Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165: 6107-6115
28. Li H., Chen J., Huang A., Stinson J., Heldens S., Foster J. et al. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97: 773-778
29. Shi Y., Ullrich S. J., Zhang J., Connolly K., Grzegorzewski K. J., Barber M. C. et al. (2000) A novel cytokine receptor-ligand pair. Identification, molecular characterization and in vivo immunomodulatory activity. J. Biol. Chem. 275: 19167-19176
30. Lee J., Ho W. H., Maruoka M., Corpuz R. T., Baldwin D. T., Foster J. S. et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660-1664
31. Starnes T., Broxmeyer H. E., Robertson M. J. and Hromas R. (2002) IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169: 642-646
32. Starnes T., Robertson M. J., Sledge G., Kelich S., Nakshatri H., Broxmeyer H. E. et al. (2001) IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167: 4137-4140
33. Fort M. M., Cheung J., Yen D., Li J., Zurawski S. M., Lo S. et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995
34. Ikeda K., Nakajima H., Suzuki K., Kagami S., Hirose K., Suto A. et al. (2003) Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 101: 3594-3596
35. Kim M. R., Manoukian R., Yeh R., Silbiger S. M., Danilenko D. M., Scully S. et al. (2002) Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia and altered antibody production. Blood 100: 2330-2340
36. Kawaguchi M., Onuchic L. F., Li X. D., Essayan D. M., Schroeder J., Xiao H. Q. et al. (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167: 4430-4435
37. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H. et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164: 2832-2838
38. Aggarwal S., Ghilardi N., Xie M. H., de Sauvage F. J. and Gurney A. L. (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914
39. Oppmann B., Lesley R., Blom B., Timans J. C., Xu Y., Hunte B. et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725
40. Miyamoto M., Prause O., Sjostrand M., Laan M., Lotvall J. and Linden A. (2003) Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170: 4665-4672
41. Oda T., Yoshie H. and Yamazaki K. (2003) Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol. Immunol. 18: 30-36
42. Luzza F., ParrelloT., Monteleone G., Sebkova L., Romano M., Zarrilli R. et al. (2000) Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165: 5332-5337
43. Ye P., Garvey P. B., Zhang P., Nelson S., Bagby G., Summer W. R. et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340
44. Hurst S. D., Muchamuel T., Gorman D. M., Gilbert J. M., Clifford T., Kwan S. et al. (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169: 443-453
45. Yao Z., Spriggs M. K., Derry J. M., Strockbine L., Park L. S., VandenBos T. et al. (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9: 794-800
46. Haudenschild D. R., Moseley T. A., Rose L. M. and Reddi A. H. (2001) Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing, and expression in prostate cancer. J. Biol. Chem. 277: 4309-4316
47. Yang R. B., Ng C. K., Wasserman S. M., Komuves L. G., Gerritsen M. E. and Topper J. N. (2003) A novel IL-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling. J. Biol. Chem. 278: 33232-33238
48. Schwandner R., Yamaguchi K. and Cao Z. (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191: 1233-1240
49. Jovanovic D. V., Di Battista J. A., Martel P. J., Jolicoeur F. C., He Y., Zhang M. et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160: 3513-3521
50. Shalom-Barak T., Quach J. and Lotz M. (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 273: 27467-27473
51. Martel-Pelletier J., Mineau F., Jovanovic D., Di Battista J. A. and Pelletier J. P. (1999) Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum. 42: 2399-2409
52. Awane M., Andres P. G., Li D. J. and Reinecker H. C. (1999) NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162: 5337-5344
53. Andoh A., Takaya H., Makino J., Sato H., Bamba S., Araki Y. et al. (2001) Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin. Exp. Immunol. 125: 56-63
54. Hata K., Andoh A., Shimada M., Fujino S., Bamba S., Araki Y. et al. (2002) IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G1035-G1044
55. Shimada M., Andoh A., Hata K., Tasaki K., Araki Y., Fujiyama Y. et al. (2002) IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 168: 861-868
56. Lee J., Ho W. H., Maruoka M., Corpuz R. T., Baldwin D. T., Foster J. S. et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660-1664
57. Andoh A., Shimada M., Bamba S., Okuno T., Araki Y., Fujiyama Y. et al. (2002) Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17 plus tumor necrosis factor-alpha-induced stabilization of interleukin-6 mRNA in human pancreatic myofibroblasts. Biochim. Biophys. Acta 1591: 69-74
58. Kehlen A., Thiele K., Riemann D. and Langner J. (2002) Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol. 127: 539-546
59. Laan M., Lotvall J., Chung K. F. and Linden A. (2001) IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br. J. Pharmacol. 133: 200-206
60. Hsieh H. G., Loong C. C. and Lin C. Y. (2002) Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells. Cytokine 19: 159-174
61. Faour W. H., Mancini A., He Q. W. and Di Battista J. A. (2003) T-cell derived interleukin-17 regulates the level and stability of cyclooxygenase -2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase casade. Role of distal sequences in the 3′-untranslated region (UTR) of COX-2 mRNA. J. Biol. Chem. 278: 26897-26907
62. Subramaniam S. V., Cooper R. S. and Adunyah S. E. (1999) Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem. Biophys. Res. Commun. 262: 14-19
63. Laan M., Cui Z. H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D. C. et al. (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162: 2347-2352
64. Witowski J., Pawlaczyk K., Breborowicz A., Scheuren A., Kuzlan-Pawlaczyk M., Wisniewska J. et al. (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165: 5814-5821
65. Laan M., Prause O., Miyamoto M., Sjostrand M., Hytonen A. M., Kaneko T. et al. (2003) A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur. Respir. J. 21: 387-393
66. Albanesi C., Cavani A. and Girolomoni G. (1999) IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J. Immunol. 162: 494-502
67. Maertzdorf J., Osterhaus A. D. and Verjans G. M. (2002) IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 169: 5897-5903
68. Andoh A., Fujino S., Bamba S., Araki Y., Okuno T., Bamba T. et al. (2002) IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J. Immunol. 169: 1683-1687
69. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I. et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387
70. Ye P., Rodriguez F. H., Kanaly S., Stocking K. L., Schurr J., Schwarzenberger P. et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment and host defense. J. Exp. Med. 194: 519-527
71. van Kooten C., Boonstra J. G., Paape M. E., Fossiez F., Banchereau J., Lebecque S. et al. (1998) Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol. 9: 1526-1534
72. Katz Y., Nadiv O., Rapoport M. J. and Loos M. (2000) IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol. 120: 22-29
73. Teunissen M. B., Koomen C. W., de Waal M. R., Wierenga E. A. and Bos J. D. (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111: 645-649
74. Katz Y., Nadiv O. and Beer Y. (2001) Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6 and 8 in skin and synovial fibroblasts: a possible role as a 'fine-tuning cytokine' in inflammation processes. Arthritis Rheum. 44: 2176-2184
75. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E. et al. (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 59: 3698-3704
76. Jones C. E. and Chan K. (2002) Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha and granulocyte-colony- stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26: 748-753
77. Takaya H., Andoh A., Makino J., Shimada M., Tasaki K., Araki Y. et al. (2002) Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts. Scand. J. Gastroenterol. 37: 239-245
78. Cai X. Y., Gommoll-CP J., Justice L., Narula S. K. and Fine J. S. (1998) Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol. Lett. 62: 51-58
79. Prause O., Laan M., Lotvall J. and Linden A. (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha-and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol. 462: 193-198
80. Trajkovic V., Stosic-Grujicic S., Samardzic T., Markovic M., Miljkovic D., Ramic Z. et al. (2001) Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 119: 183-191
81. Miljkovic D., Cvetkovic I., Vuckovic O., Stosic-Grujicic S., Mostarica S. M. and Trajkovic V. (2003) The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells. Cell. Mol. Life Sci. 60: 518-525
82. Schwarzenberger P., La Russa V., Miller A., Ye P., Huang W., Zieske A. et al. (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161: 6383-6389
83. Schwarzenberger P., Huang W., Ye P., Oliver P., Manuel M., Zhang Z. et al. (2000) Requirement of endogenous stem cell factor and granulocyte-colony- stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 164: 4783-4789
84. Schwarzenberger P., Huang W., Oliver P., Byrne P., La Russa V, Zhang Z. et al. (2001) IL-17 mobilizes peripheral blood stem cells with short-and long-term repopulating ability in mice. J. Immunol. 167: 2081-2086
85. Forlow S. B., Schurr J. R., Kolls J. K., Bagby G. J., Schwarzenberger P. O. and Ley K. (2001) Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98: 3309-3314
86. Miyamoto M., Emoto M., Emoto Y., Brinkmann V., Yoshizawa I., Seiler P. et al. (2003) Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: possible contribution of granulocyte-colony-stimulating factor and IL-17. J. Immunol. 170: 5228-5234
87. Pan G., French D., Mao W., Maruoka M., Risser P., Lee J. et al. (2001) Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response and multiorgan inflammation in mice. J. Immunol. 167: 6559-6567
88. Laan M. and Linden (2002) IL-17 as a potential target for modulating airway neutrophilia. Curr. Pharm. Des. 8: 1855-1861
89. Linden A. (2001) Role of interleukin-17 and the neutrophil in asthma. Int. Arch. Allergy Immunol. 126: 179-184
90. Linden A., Hoshino H. and Laan M. (2000) Airway neutrophils and interleukin-17. Eur. Respir. J. 15: 973-977
91. Laan M., Palmberg L., Larsson K. and Linden A. (2002) Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur. Respir. J. 19: 534-537
92. Kawaguchi M., Kokubu F., Kuga H., Matsukura S., Hoshino H., Ieki K. et al. (2001) Modulation of bronchial epithelial cells by IL-17. J. Allergy Clin. Immunol. 108: 804-809
93. Hoshino H., Lotvall J., Skoogh B. E. and Linden A. (1999) Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. Am. J. Respir. Crit. Care Med. 159: 1423-1428
94. Hoshino H., Laan M., Sjostrand M., Lotvall J., Skoogh B. E. and Linden A. (2000) Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J. Allergy Clin. Immunol. 105: 143-149
95. Chakir J., Shannon J., Molet S., Fukakusa M., Elias J., Laviolette M. et al. (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111: 1293-1298
96. Wong C. K., Ho C. Y., Ko F. W., Chan C. H., Ho A. S., Hui D. S. et al. (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 125: 177-183
97. Barczyk A., Pierzchala W. and Sozanska E. (2003) Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97: 726-733
98. Hellings P. W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L. et al. (2003) Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28: 42-50
99. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M. M. and Wu R. (2003) Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278: 17036-17043
100. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170: 1958-1963
101. - T cells regulate surgical and postinfectious adhesion formation. J. Exp. Med. 195: 1471-1478
102. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S. et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352
103. Jovanovic D. V., Martel-Pelletier J., Di Battista J. A., Mineau F., Jolicoeur F. C., Benderdour M. et al. (2000) Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum. 43: 1134-1144
104. Chabaud M., Durand J. M., Buchs N., Fossiez F., Page G., Frappart L. et al. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963-970
105. Miossec P. (2003) Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48: 594-601
106. Buchan G., Barrett K., Turner M., Chantry D., Maini R. N. and Feldmann M. (1988) Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin. Exp. Immunol. 73: 449-455
107. Saxne T., Palladino M. A. Jr, Heinegard D., Talal N. and Wollheim F. A. (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31: 1041-1045
108. Hopkins S. J., Humphreys M. and Jayson M. I. (1988) Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin. Exp. Immunol. 72: 422-427
109. Kehlen A., Pachnio A., Thiele K. and Langner J. (2003) Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res. Ther. 5: R186-R192
110. Chabaud M., Page G. and Miossec P. (2001) Enhancing effect of IL-1, IL-17 and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol. 167: 6015-6020
111. Chabaud M., Fossiez F., Taupin J. L. and Miossec P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 161: 409-414
112. Wong P. K., Campbell I. K., Egan P. J., Ernst M. and Wicks I. P (2003) The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum. 48: 1177-1189
113. Lubberts E., Joosten L. A., van de Loo F. A., van den Gersselaar L. A. and van Den Berg W. B. (2000) Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum. 43: 1300-1306
114. Koshy P. J., Henderson N., Logan C., Life P. F., Cawston T. E. and Rowan A. D. (2002) Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann. Rheum. Dis. 61: 704-713
115. Chabaud M., Garnero P., Dayer J. M., Guerne P. A., Fossiez F. and Miossec P. (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092-1099
116. Benderdour M., Tardif G., Pelletier J. P., Di Battista J. A., Reboul P., Ranger P. et al. (2002) Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J. Rheumatol. 29: 1262-1272
117. Chabaud M., Lubberts E., Joosten L., van Den B. W. and Miossec P. (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 3: 168-177
118. Cai L., Yin J. P., Starovasnik M. A., Hogue D. A., HillanK. J., Mort J. S. et al. (2001) Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 16: 10-21
119. Lubberts E., Joosten L. A., Oppers B., van Den B. L., Coenende Roo C. J., Kolls J. K. et al. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167: 1004-1013
120. Bush K. A., Farmer K. M., Walker J. S. and Kirkham B. W. (2002) Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 46: 802-805
121. Burchill M. A., Nardelli D. T., England D. M., DeCoster D. J., Christopherson J. A., Callister S. M. et al. (2003) Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71: 3437-3442
122. Lubberts E., van Den B. L., Oppers-Walgreen B., Schwarzenberger P., Coenen-De Roo C. J., Kolls J. K. et al. (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappaB ligand/osteoprotegerin balance. J. Immunol. 170: 2655-2662
123. Nakae S., Saijo S., Horai R., Sudo K., Mori S. and Iwakura Y. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100: 5986-5990
124. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y. et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70
125. Nielsen O. H., Kirman I., Rudiger N., Hendel J. and Vainer B. (2003) Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38: 180-185
126. Bamba S., Andoh A., Yasui H., Araki Y., Bamba T. and Fujiyama Y. (2003) Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J. Gastroenterol. 38: 548-554
127. Andoh A., Hata K., Araki Y., Fujiyama Y. and Bamba T. (2002) Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonie myofibroblasts. Int. J. Mol. Med. 10: 631-634
128. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H. et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508
129. Matusevicius D., Kivisakk P., He B., Kostulas N., Ozenci V., Fredrikson S. et al. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104
130. Pelidou S. H., Zou L. P., Deretzi G., Oniding C., Mix E. and Zhu J. (2000) Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Exp. Neurol. 163: 165-172
131. Loong C. C., Hsieh H. G., Lui W. Y., Chen A. and Lin C. Y. (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J. Pathol. 197: 322-332
132. Hsieh H. G., Loong C. C., Lui W. Y., Chen A. and Lin C. Y. (2001) IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl. Int. 14: 287-298
133. Woltman A. M., de Haij S., Boonstra J. G., Gobin S. J., Daha M. R. and van Kooten C. (2000) Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J. Am. Soc. Nephrol. 11: 2044-2055
134. Antonysamy M. A., Fanslow W. C., Fu F., Li W., Qian S., Troutt A. B. et al. (1999) Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival. Transplant. Proc. 31: 93
135. Antonysamy M. A., Fanslow W. C., Fu F., Li W., Qian S., Troutt A. B. et al. (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 162: 577-584
136. Tang J. L., Subbotin V. M., Antonysamy M. A., Troutt A. B., Rao A. S. and Thomson A. W. (2001) Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72: 348-350
137. Numasaki M., Fukushi J., Ono M., Narula S. K., Zavodny P. J., Kudo T. et al. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627
138. Kato T., Furumoto H., Ogura T., Onishi Y., Irahara M., Yamano S. et al. (2001) Expression of IL-17 mRNA in ovarian cancer. Biochem. Biophys. Res. Commun. 282: 735-738
139. Hirahara N., Nio Y., Sasaki S., Minari Y., Takamura M., Iguchi C. et al. (2001) Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology 61: 79-89
140. Hirahara N., Nio Y., Sasaki S., Takamura M., Iguchi C., Dong M. et al. (2000) Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Res. 20: 3137-3142
141. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautes-Fridman C. et al. (2002) Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99: 2114-2121
142. Aggarwal S. and Gurney A. L. (2002) IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71: 1-8